# Efficacy and Safety of Rejuviel V in the Correction of Midface Volume Deficit

> **NCT07162610** · NA · ACTIVE_NOT_RECRUITING · sponsor: **PharmaResearch Co.,Ltd** · enrollment: 89 (actual)

## Conditions studied

- Mid-face Volume Deficit

## Interventions

- **DEVICE:** Rejuviel V® with lidocaine
- **DEVICE:** JUVEDERM® VOLUMA® with lidocaine

## Key facts

- **NCT ID:** NCT07162610
- **Lead sponsor:** PharmaResearch Co.,Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-04-07
- **Primary completion:** 2026-03-08
- **Final completion:** 2026-03-30
- **Target enrollment:** 89 (ACTUAL)
- **Last updated:** 2025-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07162610

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07162610, "Efficacy and Safety of Rejuviel V in the Correction of Midface Volume Deficit". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT07162610. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*